Management tracks

Cancer company Infinity Pharmaceuticals Inc. (NASDAQ:INFI) said President of R&D Julian Adams will retire, effective Jan. 6. The company promoted Lawrence Bloch to president from CFO. The company also promoted Claudio Dansky Ullmann to SVP of clinical development from VP.

Oncology company Cascadian Therapeutics Inc. (NASDAQ:CASC) named Marc Lesnick SVP of regulatory affairs and quality. He was SVP of U.S. regulatory affairs and global development projects at the U.S. subsidiary of Shionogi & Co. Ltd. (Tokyo:4507)...